Skip to main content

Advertisement

Log in

Platelet-rich plasma vs. steroid injections for hamstring injury—is there really a choice?

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objective

To assess the effectiveness of pain relief in patients with grade 2 proximal hamstring injury, treated with platelet-rich plasma (PRP) or corticosteroid injection, by using the primary outcome of visual analog scale (VAS) at 1 week and 4 weeks of follow-up.

Materials and methods

A single institution retrospective study was performed for image-guided PRP or steroid injections between 12/1/2015 and 10/30/2017 for proximal hamstring injuries. VAS was measured at 1 week and 4 weeks post-injection via telephone interviews and the pain response was recorded into two groups (negative/no change vs. positive). A comparison of pain responses between PRP and steroid was conducted by generalized estimating equation.

Results

Among 56 patients, 32 received PRP and 24 received steroid injections with ages from 13 to 75 years old. At 1 week post-injection follow-up, 23 patients (71.9%) from the PRP group and 11 patients (45.8%) from the steroid group showed positive response. After controlling for age, pre-procedure pain level, and gender, the positive response rate in the PRP group was higher than the steroid group (aOR: 4.04, 95% CI: 1.04–15.63, p value = 0.04). At 4 weeks post-injection, 23 patients (71.9%) from the PRP group and 13 patients (54.2%) from the steroid group showed positive response with no statistical significance (aOR: 2.48, 95% CI: 0.63–9.79, p value = 0.19).

Conclusions

The PRP group had shown more favorable response compared to steroid group at 1 week post-injection, which suggests that PRP therapy can be considered as a conservative treatment choice for grade 2 proximal hamstring injuries with better short-term pain relief based on limited pilot data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lempainen L, Sarimo J, Mattila K, et al. Proximal hamstring tendinopathy: results of surgical management and histopathologic findings. Am J Sports Med. 2009;37:727–34.

    Article  PubMed  Google Scholar 

  2. Chaudhury S, De La Lama M, Adler RS, et al. Platelet-rich plasma for the treatment of lateral epicondylitis: sonographic assessment of tendon morphology and vascularity (pilot study). Skelet Radiol. 2013;42:91–7.

    Article  Google Scholar 

  3. Van Den Dolder J, Mooren R, Vloon A, et al. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng Part A. 2010;16:1021–9.

    Article  Google Scholar 

  4. Sampson S, Gerhardt M, Mandelbaum B. Platelet-rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskeletal Med. 2008;1:165–74.

    Article  Google Scholar 

  5. Menetrey J, Kasemkijwattana C, Day C, et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg (Br). 2000;82:131–7.

    Article  CAS  Google Scholar 

  6. Crane D, Everts P. Platelet-rich plasma (PRP) matrix graphs. Pract Pain Manag. 2008;8(1):12–26.

    Google Scholar 

  7. Foster T, Puskas B, Mandelbaum B, et al. Platelet-rich plasma from basic science to clinical applications. AM J Sports Med. 2009;37:2259–72.

    Article  PubMed  Google Scholar 

  8. Karli D, Robinson B. Platelet-rich plasma for hamstring tears. Pract Pain Manag. 2010;10(5):17–18.

    Google Scholar 

  9. Habib GS, Saliba W, Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol. 2010;29:347–56.

    Article  PubMed  Google Scholar 

  10. Diiorio TM, Burkholder JD, Good RP, Parvizi J, Sharkey PF. Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA. Clin Orthop Relat Res. 2012;470:138–43.

    Article  PubMed  Google Scholar 

  11. Lai LP, Stitik TP, Foye PM, Georgy JS, Patibanda V, Chen B. Use of platelet-rich plasma in intra-articular knee injections for osteoarthritis: a systematic review. PM R. 2015;7:637–48.

    Article  PubMed  Google Scholar 

  12. Milants C, Bruyere O, Kaux JF. Responders to platelet-rich plasma in osteoarthritis: a technical analysis. Biomed Res Int. 2017;2017:7538604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hamid MS, Mohamed Ali MR, Yusof A, et al. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. 2014;42(10):2410–8.

    Article  Google Scholar 

  14. Mlynarek RA, Kuhn AW, Bedi A. Platelet-rich plasma in orthopedic sports medicine. Am J Orthop. 2016;45(5):290–326.

    PubMed  Google Scholar 

  15. Wetzel RJ, Patel RM, Terry MA. Platelet-rich plasma as an effective treatment for proximal hamstring injuries. Orthopedics. 2013;36(1):e64–70.

    Article  PubMed  Google Scholar 

  16. De Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;13(303):144–9.

    Article  Google Scholar 

  17. De Vos RJ, Windt J, Weir A. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014;48:952–6.

    Article  PubMed  Google Scholar 

  18. Bird SB, Dickson EW. Clinically significant changes in pain along the visual analog scale. Ann Emerg Med. 2001;38:639–43.

    Article  CAS  PubMed  Google Scholar 

  19. Nourissat G, Ornetti P, Berenbaum F, et al. Does platelet-rich plasma deserve a role in the treatment of tendinopathy? Joint Bone Spine. 2015;82(4):230–4.

    Article  PubMed  Google Scholar 

  20. Dean BJ, Lostis E, Oakley T, et al. The risks and benefits of glucocorticoid treatment for tendinopathy: a systemic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum. 2014;43(4):570–6.

    Article  CAS  PubMed  Google Scholar 

  21. Drezner JA. Practical management: hamstring muscle injuries. Clin J Sport Med. 2003;13(1):48–52.

    Article  PubMed  Google Scholar 

  22. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Phys Sportsmed. 2011;39(3):94–9.

    Article  PubMed  Google Scholar 

  23. Davenport KL, Campos JS, Nguyen J, et al. Ultrasound-guided intratendinous injections with platelet-rich plasma or autologous whole blood for treatment of proximal hamstring tendinopathy. J Ultrasound Med. 2015;34:1455–63.

    Article  PubMed  Google Scholar 

  24. Hamid MS, Ali MR, Yusof A, et al. Platelet-rich plasma: an adjuvant to hasten hamstring muscle recovery. A randomized controlled trial protocol. BMC Musculoskelet Disord. 2012;13:138.

    Article  Google Scholar 

  25. Gautam VK, Verma S, Batra S, et al. Platelet-rich plasma versus corticosteroid injection for recalcitrant lateral epicondylitis: clinical and ultrasonographic evaluation. J Orthop Surg. 2015;23(1):1–5.

    Article  CAS  Google Scholar 

  26. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Yong Soo Park.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, P.Y.S., Cai, C., Bawa, P. et al. Platelet-rich plasma vs. steroid injections for hamstring injury—is there really a choice?. Skeletal Radiol 48, 577–582 (2019). https://doi.org/10.1007/s00256-018-3063-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-018-3063-9

Keywords

Navigation